WW International Inc. (WW)
NASDAQ (NGS) NASDAQ (NGS) Primary 
WW International, Inc. (WW) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
WW International, Inc. (WW) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Weight Watchers names Stephen Bye as CEO
WW International on Wednesday named Stephen Bye as its chief executive officer, effective this fall.
WW International, Inc. (WW) Q2 2026 Earnings Call Transcript
WW International, Inc. (WW) Q2 2026 Earnings Call Transcript
WW International Q2 Earnings Call Highlights
WW International NASDAQ: WW, the parent company of Weight Watchers, reported second-quarter 2026 revenue of $162.3 million, down from $189.2 million a year earlier, while highlighting growth in its clinical and higher-value behavioral membership tiers and reaffirming its full-year financial outlook.
WW International, Inc. (WW) Q1 2026 Earnings Call Transcript
WW International, Inc. (WW) Q1 2026 Earnings Call Transcript
WW International Q1 Earnings Call Highlights
WW International NASDAQ: WW, operator of WeightWatchers, reaffirmed its 2026 financial outlook after reporting first-quarter results that reflected continued pressure in its legacy behavioral subscription business, offset in part by growth in its clinical weight-management offering and higher-value membership tiers.
WW International Logs Lower Sales
WW International posted lower revenue in the first quarter, as behavioral subscription sales fell.
WW International: First Normal Quarter Shows Signs Of Stability
WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cautious Q4 guidance, which may keep investors wary until trends improve. Key catalysts ahead include FDA decisions on GLP-1 compounding, expanded insurance coverage, and new partnerships with pharma and insurance providers.
WeightWatchers to offer faster delivery of weight loss drugs through new partnership with Amazon Pharmacy
Weight management company WW International, also known as WeightWatchers (NASDAQ:WW), has partnered with Amazon Pharmacy to streamline access to weight management medications for WeightWatchers Clinic members. Under the partnership, members can view real-time medication availability, compare delivery options, and receive prescriptions through Amazon Pharmacy.
WW International, Inc. (WW) Q2 2025 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW ) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants David Helderman - Director of Investor Relations Felicia DellaFortuna - Chief Financial Officer Jon Volkmann - Chief Operations Officer Tara M. Comonte - President, CEO & Director Conference Call Participants Alex Joseph Fuhrman - Lucid Capital Markets, LLC, Research Division Nathaniel Jay Feather - Morgan Stanley, Research Division Operator Good day, and welcome to the WeightWatchers Second Quarter 2025 Earnings Conference Call.
WeightWatchers reboots with focus on medical weight-loss and menopause care
Weight Watchers International (NASDAQ:WW) has emerged from bankruptcy with a renewed strategy, aiming to combine medical weight-loss treatments with long-term lifestyle support. The company cleared over $1.15 billion of debt, more than 70% of its total, through a US court restructuring process, strengthening its financial position.
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared bankruptcy this week, citing vastly increased use of the new blockbuster medicines.
